BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 23659962)

  • 1. Enrichment map profiling of the cancer invasion front suggests regulation of colorectal cancer progression by the bone morphogenetic protein antagonist, gremlin-1.
    Karagiannis GS; Berk A; Dimitromanolakis A; Diamandis EP
    Mol Oncol; 2013 Aug; 7(4):826-39. PubMed ID: 23659962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression patterns of bone morphogenetic protein antagonists in colorectal cancer desmoplastic invasion fronts.
    Karagiannis GS; Treacy A; Messenger D; Grin A; Kirsch R; Riddell RH; Diamandis EP
    Mol Oncol; 2014 Oct; 8(7):1240-52. PubMed ID: 24812030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic signatures of the desmoplastic invasion front reveal collagen type XII as a marker of myofibroblastic differentiation during colorectal cancer metastasis.
    Karagiannis GS; Petraki C; Prassas I; Saraon P; Musrap N; Dimitromanolakis A; Diamandis EP
    Oncotarget; 2012 Mar; 3(3):267-85. PubMed ID: 22408128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone morphogenetic protein antagonist gremlin-1 regulates colon cancer progression.
    Karagiannis GS; Musrap N; Saraon P; Treacy A; Schaeffer DF; Kirsch R; Riddell RH; Diamandis EP
    Biol Chem; 2015 Feb; 396(2):163-83. PubMed ID: 25153376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gremlin-1: An endogenous BMP antagonist induces epithelial-mesenchymal transition and interferes with redifferentiation in fetal RPE cells with repeated wounds.
    Li D; Yuan D; Shen H; Mao X; Yuan S; Liu Q
    Mol Vis; 2019; 25():625-635. PubMed ID: 31700227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer-associated fibroblast-derived Gremlin 1 promotes breast cancer progression.
    Ren J; Smid M; Iaria J; Salvatori DCF; van Dam H; Zhu HJ; Martens JWM; Ten Dijke P
    Breast Cancer Res; 2019 Sep; 21(1):109. PubMed ID: 31533776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Balance of Stromal BMP Signaling Mediated by GREM1 and ISLR Drives Colorectal Carcinogenesis.
    Kobayashi H; Gieniec KA; Wright JA; Wang T; Asai N; Mizutani Y; Lida T; Ando R; Suzuki N; Lannagan TRM; Ng JQ; Hara A; Shiraki Y; Mii S; Ichinose M; Vrbanac L; Lawrence MJ; Sammour T; Uehara K; Davies G; Lisowski L; Alexander IE; Hayakawa Y; Butler LM; Zannettino ACW; Din MO; Hasty J; Burt AD; Leedham SJ; Rustgi AK; Mukherjee S; Wang TC; Enomoto A; Takahashi M; Worthley DL; Woods SL
    Gastroenterology; 2021 Mar; 160(4):1224-1239.e30. PubMed ID: 33197448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential gene expression and regulation of the bone morphogenetic protein antagonists follistatin and gremlin in normal and osteoarthritic human chondrocytes and synovial fibroblasts.
    Tardif G; Hum D; Pelletier JP; Boileau C; Ranger P; Martel-Pelletier J
    Arthritis Rheum; 2004 Aug; 50(8):2521-30. PubMed ID: 15334466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone morphogenetic protein 4 inhibits TGF-beta2 stimulation of extracellular matrix proteins in optic nerve head cells: role of gremlin in ECM modulation.
    Zode GS; Clark AF; Wordinger RJ
    Glia; 2009 May; 57(7):755-66. PubMed ID: 19031438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown GREM1 suppresses cell growth, angiogenesis, and epithelial-mesenchymal transition in colon cancer.
    Liu Y; Li Y; Hou R; Shu Z
    J Cell Biochem; 2019 Apr; 120(4):5583-5596. PubMed ID: 30426548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation.
    Sneddon JB; Zhen HH; Montgomery K; van de Rijn M; Tward AD; West R; Gladstone H; Chang HY; Morganroth GS; Oro AE; Brown PO
    Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14842-7. PubMed ID: 17003113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gremlin is a key pro-fibrogenic factor in chronic pancreatitis.
    Staloch D; Gao X; Liu K; Xu M; Feng X; Aronson JF; Falzon M; Greeley GH; Rastellini C; Chao C; Hellmich MR; Cao Y; Ko TC
    J Mol Med (Berl); 2015 Oct; 93(10):1085-1093. PubMed ID: 26141517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of gremlin, a BMP antagonist, and epithelial-to-mesenchymal transition in proliferative vitreoretinopathy.
    Lee H; O'Meara SJ; O'Brien C; Kane R
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4291-9. PubMed ID: 17724219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gremlin-mediated decrease in bone morphogenetic protein signaling promotes aristolochic acid-induced epithelial-to-mesenchymal transition (EMT) in HK-2 cells.
    Li Y; Wang Z; Wang S; Zhao J; Zhang J; Huang Y
    Toxicology; 2012 Jul; 297(1-3):68-75. PubMed ID: 22525892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 33/ST2 Axis Components Are Associated to Desmoplasia, a Metastasis-Related Factor in Colorectal Cancer.
    Landskron G; De la Fuente López M; Dubois-Camacho K; Díaz-Jiménez D; Orellana-Serradell O; Romero D; Sepúlveda SA; Salazar C; Parada-Venegas D; Quera R; Simian D; González MJ; López-Köstner F; Kronberg U; Abedrapo M; Gallegos I; Contreras HR; Peña C; Díaz-Araya G; Roa JC; Hermoso MA
    Front Immunol; 2019; 10():1394. PubMed ID: 31281317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulinlike growth factor-I-mediated migration and invasion of human colon carcinoma cells requires activation of c-Met and urokinase plasminogen activator receptor.
    Bauer TW; Fan F; Liu W; Johnson M; Parikh NU; Parry GC; Callahan J; Mazar AP; Gallick GE; Ellis LM
    Ann Surg; 2005 May; 241(5):748-56; discussion 756-8. PubMed ID: 15849510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of TGF-beta2, BMP-4, and gremlin in the trabecular meshwork: implications for glaucoma.
    Wordinger RJ; Fleenor DL; Hellberg PE; Pang IH; Tovar TO; Zode GS; Fuller JA; Clark AF
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1191-200. PubMed ID: 17325163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of SMAD4 alters BMP signaling to promote colorectal cancer cell metastasis via activation of Rho and ROCK.
    Voorneveld PW; Kodach LL; Jacobs RJ; Liv N; Zonnevylle AC; Hoogenboom JP; Biemond I; Verspaget HW; Hommes DW; de Rooij K; van Noesel CJ; Morreau H; van Wezel T; Offerhaus GJ; van den Brink GR; Peppelenbosch MP; Ten Dijke P; Hardwick JC
    Gastroenterology; 2014 Jul; 147(1):196-208.e13. PubMed ID: 24704720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-β2 promotes RPE cell invasion into a collagen gel by mediating urokinase-type plasminogen activator (uPA) expression.
    Sugioka K; Kodama A; Okada K; Iwata M; Yoshida K; Kusaka S; Matsumoto C; Kaji H; Shimomura Y
    Exp Eye Res; 2013 Oct; 115():13-21. PubMed ID: 23810810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parathyroid Hormone-Related Protein Interacts With the Transforming Growth Factor-β/Bone Morphogenetic Protein-2/Gremlin Signaling Pathway to Regulate Proinflammatory and Profibrotic Mediators in Pancreatic Acinar and Stellate Cells.
    Bhatia V; Cao Y; Ko TC; Falzon M
    Pancreas; 2016; 45(5):659-70. PubMed ID: 26495794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.